ArticleCancer cellPublished
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Cancer cell
- Published
- Topic
- Disease research
- Subject terms
- Cell Line, Tumor; Animals; Humans; Mice; Melanoma; Proto-Oncogene Proteins B-raf; Antineoplastic Combined Chemotherapy Protocols; Protein Kinase Inhibitors; Immunotherapy; Xenograft Model Antitumor Assays; Apoptosis; MAP Kinase Signaling System
- PubMed ID
- 40020669
- PubMed Central ID
- PMC11903146
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked